Berberine targets KIF20A and CCNE2 to inhibit the progression of nonsmall cell lung cancer via the PI3K/AKT pathway.

MLA

Wang, Qi, et al. “Berberine Targets KIF20A and CCNE2 to Inhibit the Progression of Nonsmall Cell Lung Cancer via the PI3K/AKT Pathway.” Drug Development Research, vol. 84, no. 5, Aug. 2023, pp. 907–21. EBSCOhost, https://doi.org/10.1002/ddr.22061.

APA

Wang, Q., Wu, H., Wu, Q., & Zhong, S. (2023). Berberine targets KIF20A and CCNE2 to inhibit the progression of nonsmall cell lung cancer via the PI3K/AKT pathway. Drug Development Research, 84(5), 907–921. https://doi.org/10.1002/ddr.22061

Chicago

Wang, Qi, Hua Wu, Qingquan Wu, and Sheng Zhong. 2023. “Berberine Targets KIF20A and CCNE2 to Inhibit the Progression of Nonsmall Cell Lung Cancer via the PI3K/AKT Pathway.” Drug Development Research 84 (5): 907–21. doi:10.1002/ddr.22061.